Anavex Life Sciences Corp (AVXL)

[Alinea818]

TauRx...
"It is VERY obvious that 2-73 is going to be successful all the way till 52 weeks in phase 2, AND in their double blinded phase 2/3.
WHY ? They are focusing on blocking Tau, not beta-amyloid. That is similar to what TauRX is doing, and they had successful phase 2. That is the new approach and it works. But TauRX does not reverse, like 2-73 does.
If TauRx comes IPO with 2 billion market cap (I think it will be most likely $4 billion), AVXL should be worth 3x to 4x current market cap.

Wischik, a professor at the University of Aberdeen in Scotland, has spent his career looking for a drug to dissolve tangles of a protein called tau, one of the hallmarks of Alzheimer’s brain abnormalities. The majority of Alzheimer’s researchers have focused on another kind of protein clump known as beta-amyloid, which has had mixed results.

Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, said, “Using further upstream targets that efficiently block tau phosphorylation and amyloid overproduction might be a more comprehensive approach in successfully treating this complex disease."

Posted by "doing_good123"